TITLE

Surface contamination of antineoplastic drug vials: Comparison of unprotected and protected vials

AUTHOR(S)
Schierl, Rudolf; Herwig, Autenrieth; Pfaller, Andreas; Groebmair, Stefan; Fischer, Elke
PUB. DATE
March 2010
SOURCE
American Journal of Health-System Pharmacy;3/15/2010, Vol. 67 Issue 6, p428
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the contamination of outside of vials that contain antineoplastic drugs. It states that the contamination may have been caused by personnel of hospital pharmacies being contaminated when preparing antineoplastic drugs even if safety guidelines are complied during preparation. It examines the methods introduced by pharmaceutical manufacturers to prevent exposure from outside contamination which include safety sheeting systems where the vial is packed in plastic container.
ACCESSION #
48478494

 

Related Articles

  • Working in Isolation. Bush, Laura // Pharmaceutical Technology;Mar2004, Vol. 28 Issue 3, p14 

    Comments on the two contradictory factors of isolation and integration influencing the business environment. Report on barrier/isolation technology in the pharmaceutical industry with focus on avoiding human-induced cross-contamination or protection of operators from hazardous compounds;...

  • Isolators and background environments. Neiger, John // Environmental Engineering;Dec99, Vol. 12 Issue 4, p35 

    Presents information on the use of Class 2 cabinets for cytotoxic dispensing in Australia and Great Britain. Advantages of using isolators in British hospital pharmacies; Design principles of transfer devices; Benefits of laminar flow isolators.

  • Pharma Industry Drives Innovation in Barrier/Isolation Design. Chiarello, Kaylynn // Pharmaceutical Technology;Mar2004, Vol. 28 Issue 3, p44 

    Presents a special report on the initiation of a wave of innovative solutions in barrier/isolation equipment design and implementation in the pharmaceutical industry. Creation of each piece of barrier/isolation equipment to meet both the requirements of the industry and those of the product...

  • THE CLEANING AND DISINFECTION CHALLENGE.  // Pharma Magazine;Mar/Apr2011, Vol. 7 Issue 2, p22 

    The article offers tips on cleaning and disinfecting aseptic areas for manufacturing pharmaceuticals to avoid microbial contamination. It says that good quality pH-neutral detergent must be used to remove residues and debris in aseptic areas before the application of cleaning agents. It mentions...

  • Using medium-fill simulation to establish a benchmark microbiological contamination rate for low-risk-level compounding. Trissel, Iawrence A.; Ogundele, Abayomi B.; Ingram, Delshalonda S.; Saenz, Christopher A.; Gentempo, Joseph A. // American Journal of Health-System Pharmacy;9/15/2003, Vol. 60 Issue 18, p1853 

    A benchmark contamination rate for prefilled syringe compounding was determined by using a medium-fill-simulation method. One thousand thirty-five 1-mL tuberculin syringes were aseptically filled with 0.9 mL of sterile soybean-casein digest medium and capped. These syringes were placed into...

  • Monitoring surface contamination by antineoplastic drugs using gas chromatography - mass spectrometry and voltammetry. Schmaus, Gudrun; Schierl, Rudolf; Funck, Sabine // American Journal of Health-System Pharmacy;5/15/2002, Vol. 59 Issue 10, p956 

    Investigates the surface contamination patterns by antineoplastic drugs of hospital pharmacies. Gas chromatography-mass spectrometry; Voltammetry; Drug recovery rates.

  • Microbial Stowaways in Topical Antiseptic Products. Chang, Christina Y.; Furlong, Lesley-Anne // New England Journal of Medicine;12/6/2012, Vol. 367 Issue 23, p2170 

    The article focuses on the outbreaks of infection due to antiseptic products that were contaminated with microbial organisms in the U.S. Antisepticcs that cause infections because of microbial contamination include alcohol, iodophors, chlorhexidine gluconate and quaternary ammonium products....

  • RABS and Advanced Aseptic Processing. Agalloco, James P.; Akers, James E. // Pharmaceutical Technology;2006 Supplement, Vol. 30, ps24 

    The article discusses the use of restricted access barrier systems (RABS) in aseptic processing. The contamination source strength in aseptic processing operator has been estimated in several years and technological advances have been categorized to mitigate contamination risks. An overview of...

  • The Use of Model Organisms in Sterilizing Filtration. Madsen, Russell E.; Akers, James E.; Jornitz, Maik W.; Meltzer, Theodore H. // Pharmaceutical Technology;2006 Supplement, Vol. 30, ps38 

    The article discusses the role of model organism in validating sterile filtration and the sterility of its effluent. Model organisms are useful in sterile filtration, however, there is no assurance that the effluent is sterile. The best way to determine the sterility of the effluent is to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics